Abstract |
CKD-MBD is a new clinical concept which defines a systemic disorder of mineral and bone metabolism as a result of CKD. Although various mineral metabolic factors are involved in its pathogenesis, alteration in vitamin D metabolism plays a crucial role among them. Vitamin D receptor activators (VDRAs), which are traditionally considered a cardinal treatment of secondary hyperparathyroidism, have attracted lots of attention for their potential pleiotropic effects through the activation of the vitamin D receptor expressed in multiple organs. In recent years, the deficiency of vitamin D in CKD patients also has received growing interest. The serum 25 ( OH) D levels are considered as a useful prognostic marker, and the significances of nutritional vitamin D supplementation are reviewed from a new perspective.
|
Authors | Yousuke Nakagawa, Masahiro Koizumi, Masafumi Fukagawa |
Journal | Clinical calcium
(Clin Calcium)
Vol. 25
Issue 3
Pg. 413-23
(Mar 2015)
ISSN: 0917-5857 [Print] Japan |
PMID | 25716815
(Publication Type: English Abstract, Journal Article, Review)
|
Chemical References |
- Biomarkers
- Receptors, Calcitriol
- Vitamin D
|
Topics |
- Animals
- Biomarkers
(blood)
- Bone Diseases, Metabolic
(drug therapy)
- Humans
- Receptors, Calcitriol
(metabolism)
- Renal Insufficiency, Chronic
(complications, diagnosis, metabolism)
- Vitamin D
(metabolism, pharmacology)
- Vitamin D Deficiency
(complications, metabolism)
|